Fundamental Valuation Report Albireo Pharma(ALBO:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$32.92 (USD) 04/15/2021 Weighted Valuation$31.89 (USD) Overall RatingFairly valued to slightly Overvalued by 3.1% Valuation Models Adjusted …
Albireo Pharma (ALBO:NAS) Fundamental Valuation Report Read more »
Read MoreFundamental Valuation Report Aimmune Therapeutics(AIMT:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$24.78 (USD) 04/03/2019 Weighted Valuation$44.46 (USD) Overall RatingUndervalued by 79.4% Valuation Models Analyst Consensus: $56.75 (USD) (in …
Aimmune Therapeutics (AIMT:NAS) Fundamental Valuation Report Read more »
Read MorePrint This Report was generated using the tools available on StockCalc.com. Patchell Brook Equity Analytics Inc. emphasizes that the user assumes all risks associated with the use of this report or the Stockcalc website including, but not limited to, all …
AveXis (AVXS:NAS) Fundamental Valuation Report Read more »
Read More